Shamik J Parikh

Summary

Affiliation: GlaxoSmithKline Research and Development
Country: USA

Publications

  1. ncbi The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults
    Shamik J Parikh
    GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania 19406, USA
    J Clin Endocrinol Metab 89:1196-9. 2004
  2. ncbi Rosiglitazone increases LDL particle size and buoyancy and decreases C-reactive protein in patients with type 2 diabetes on statin therapy
    Dahong Yu
    GlaxoSmithKline, King of Prussia, PA 19406, USA
    Diab Vasc Dis Res 3:189-96. 2006
  3. ncbi Indices of insulin action, disposal, and secretion derived from fasting samples and clamps in normal glucose-tolerant black and white children
    Gabriel I Uwaifo
    Unit on Growth and Obesity, Developmental Endocrinology Branch, National Institutes of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892, USA
    Diabetes Care 25:2081-7. 2002
  4. ncbi Calcium intake and adiposity
    Shamik J Parikh
    Unit on Growth and Obesity, Developmental Endocrinology Branch, National Institute of Child Health and Development, National Institutes of Health, Bethesda, MD 20892 1862, USA
    Am J Clin Nutr 77:281-7. 2003
  5. ncbi The prevalence of hypovitaminosis D and secondary hyperparathyroidism in obese Black Americans
    Lisa B Yanoff
    Unit on Growth and Obesity, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892-1103, USA
    Clin Endocrinol (Oxf) 64:523-9. 2006

Collaborators

Detail Information

Publications5

  1. ncbi The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults
    Shamik J Parikh
    GlaxoSmithKline Pharmaceuticals, King of Prussia, Pennsylvania 19406, USA
    J Clin Endocrinol Metab 89:1196-9. 2004
    ..We conclude that, because 1,25-vit D concentrations fall with increasing adiposity, it appears unlikely that elevation in 1,25-vit D is an important hormonal mechanism causing or maintaining obesity in adults...
  2. ncbi Rosiglitazone increases LDL particle size and buoyancy and decreases C-reactive protein in patients with type 2 diabetes on statin therapy
    Dahong Yu
    GlaxoSmithKline, King of Prussia, PA 19406, USA
    Diab Vasc Dis Res 3:189-96. 2006
    ..However, the increase in IDL may be proatherogenic and must be considered when assessing the benefits of rosiglitazone...
  3. ncbi Indices of insulin action, disposal, and secretion derived from fasting samples and clamps in normal glucose-tolerant black and white children
    Gabriel I Uwaifo
    Unit on Growth and Obesity, Developmental Endocrinology Branch, National Institutes of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892, USA
    Diabetes Care 25:2081-7. 2002
    ..These results, if replicated in similarly diverse populations, suggest that estimates based on fasting samples can be used to rank order insulin secretion and sensitivity in pediatric cohorts...
  4. ncbi Calcium intake and adiposity
    Shamik J Parikh
    Unit on Growth and Obesity, Developmental Endocrinology Branch, National Institute of Child Health and Development, National Institutes of Health, Bethesda, MD 20892 1862, USA
    Am J Clin Nutr 77:281-7. 2003
    ..We suggest that these data support the need for large, population based clinical trials to assess the effects of supplemental calcium and other components of dairy products on human body weight...
  5. ncbi The prevalence of hypovitaminosis D and secondary hyperparathyroidism in obese Black Americans
    Lisa B Yanoff
    Unit on Growth and Obesity, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892-1103, USA
    Clin Endocrinol (Oxf) 64:523-9. 2006
    ..Physicians should consider routinely supplementing such patients with vitamin D or screening them for hypovitaminosis D...